Viatris (VTRS) Receivables - Net (2019 - 2026)
Viatris (VTRS) posted quarterly Receivables - Net of $3.1 billion for Q1 2026, down 1.58% year-over-year from $3.1 billion in Q1 2025, and up 1.48% quarter-over-quarter from $3.0 billion in Q4 2025.
Viatris (VTRS) Receivables - Net (2019 - 2026) Analysis & Trends
Viatris' Receivables - Net history runs 8 years deep, the most recent figure standing at $3.1 billion for Q1 2026.
- In Q1 2026, Receivables - Net fell 1.58% year-over-year to $3.1 billion; the TTM figure through Mar 2026 stood at $3.1 billion (down 1.58% YoY), while the FY2025 annual figure was $3.0 billion, down 5.9% from the prior year.
- Receivables - Net for Q1 2026 stood at $3.1 billion, up from $3.0 billion in the prior quarter.
- The five-year high for Receivables - Net was $4.1 billion in Q1 2022, with the low at $3.0 billion in Q4 2025.
- The 5-year median for Receivables - Net is $3.6 billion (2024), against an average of $3.5 billion.
- The sharpest annual moves came in 2022 and 2023: Receivables - Net slipped 23.28% in 2022, then climbed 12.14% in 2023.
- Viatris' Receivables - Net stood at $3.8 billion in 2022, then dropped by 2.99% to $3.7 billion in 2023, then retreated by 12.95% to $3.2 billion in 2024, then dropped by 5.9% to $3.0 billion in 2025, then climbed by 1.48% to $3.1 billion in 2026.
- Business Quant data shows VTRS's Receivables - Net at $3.1 billion in Q1 2026, $3.0 billion in Q4 2025, and $3.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.13 Bn |
| Jun 30, 2026 | 3.13 Bn |
| Mar 31, 2026 | 3.08 Bn |
| Mar 31, 2026 | 3.08 Bn |
| Dec 31, 2025 | 3.03 Bn |
| Dec 31, 2025 | 3.03 Bn |
| Sep 30, 2025 | 3.37 Bn |
| Sep 30, 2025 | 3.37 Bn |
| Jun 30, 2025 | 3.26 Bn |
| Jun 30, 2025 | 3.26 Bn |
| Mar 31, 2025 | 3.13 Bn |
| Mar 31, 2025 | 3.13 Bn |
| Dec 31, 2024 | 3.22 Bn |
| Dec 31, 2024 | 3.22 Bn |
| Sep 30, 2024 | 3.72 Bn |
| Sep 30, 2024 | 3.72 Bn |
| Jun 30, 2024 | 3.57 Bn |
| Jun 30, 2024 | 3.57 Bn |
| Mar 31, 2024 | 3.63 Bn |
| Mar 31, 2024 | 3.63 Bn |